Etiometry

Based in Dedham, Massachusetts, Etiometry develops AI-driven clinical intelligence platforms designed for continuous patient monitoring in hospital intensive care units. The company's proprietary software integrates physiological data from multiple medical devices and electronic health records to provide predictive analytics that detect subtle patient changes and support data-driven decisions in critical care settings. Operating with a workforce of approximately 25 employees, the healthcare technology firm has secured $9.3 million in total venture funding and achieved 10 distinct FDA clearances for its algorithms. The platform is currently utilized by various academic medical centers and specialized pediatric facilities, most notably including Boston Children's Hospital. The executive leadership team includes Chief Executive Officer Shane Cooke, who previously served in management at Cheetah Medical prior to its acquisition by Baxter. Etiometry was founded in 2010 by Dimitar Baronov and Evan Butler.